Twitter storm forces Chimerix's hand in compassionate use request

Abstract

503 particularly small biotech companies that seek to keep a tight rein on limited budgets. The fracas over Chimerix’s experimental drug was particularly prominent because not only was there the emotional plight of a young child with a life-threatening disease, but there was also the immediacy and viral reach of Facebook and Twitter fueling the controversy… (More)
DOI: 10.1038/nbt0614-503

Topics

  • Presentations referencing similar topics